INTRODUCTIONThe Food and Drug Administration (FDA), in collaboration with the National Institutes of Health (NIH) and the Juvenile Diabetes Research Foundation (JDRF), is holding a public workshop that focuses on the state of the art in the research and development of an artificial pancreas. “Towards an Artificial Pancreas: An FDA-NIH-JDRF Workshop” will be held on July 21 and 22, 2008. It will provide a public forum for discussing the progress and remaining challenges in the development of closed-loop systems designed to regulate glycemic control in diabetics.
The workshop is intended to provide stakeholders with information that will accelerate the development of an artificial pancreas. World-renowned experts will present information on key topics and each session will be followed by roundtable discussions. Session topics will include:
- State-of-the-art design of closed-loop glycemic control systems
- Results of recently conducted clinical trials
- Design of clinical trials, including how to define success and failures of a closed-loop system
- Algorithms and in silico models
- Engineering challenges
- Patient considerations
- Metabolic monitoring
- Paths for developing a marketable closed-loop system
The workshop will be held from 7:55 a.m. to 6:00 p.m. on July 21 and from 8:00 a.m. to 12:45 p.m. on July 22 at the Lister Hill Auditorium on the NIH Campus (http://www.nih.gov/science/campus/index.html).
Parking is limited and public transportation is recommended (http://www.nih.gov/about/directions.htm).
For more information, see the Federal Register announcement.
